ATOVAQUONE

Generic: ATOVAQUONE, ATOVAQUONE ORAL SUSPENSION

PAI HoldingsManufacturer
ORALRoute
ATOVAQUONEActive Substance
2021-10-25Original Approval

ATOVAQUONE is FDA application ANDA214272, sponsored by PAI HOLDINGS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
OFF LABEL USE
763 reports
2
DRUG INEFFECTIVE
397 reports
3
PYREXIA
370 reports
4
DIARRHOEA
360 reports
5
PNEUMONIA
346 reports
6
NAUSEA
339 reports
7
CONDITION AGGRAVATED
273 reports
8
ACUTE KIDNEY INJURY
256 reports
9
NEUTROPENIA
250 reports
10
DEATH
246 reports